Invention Grant
US08741309B2 Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142
有权
基于分离株JA-142的猪生殖呼吸综合征疫苗
- Patent Title: Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142
- Patent Title (中): 基于分离株JA-142的猪生殖呼吸综合征疫苗
-
Application No.: US11459542Application Date: 2006-07-24
-
Publication No.: US08741309B2Publication Date: 2014-06-03
- Inventor: William L. Mengeling , Ann Vorwald , Kelly Lager , Mike Roof , Kelly Burkhart , David E. Gorcyca
- Applicant: William L. Mengeling , Ann Vorwald , Kelly Lager , Mike Roof , Kelly Burkhart , David E. Gorcyca
- Applicant Address: US DC Washington US MO St. Joseph
- Assignee: The United States of America as represented by the Secretary of Agriculture,Boehringer Ingelheim Vetmedica, Inc.
- Current Assignee: The United States of America as represented by the Secretary of Agriculture,Boehringer Ingelheim Vetmedica, Inc.
- Current Assignee Address: US DC Washington US MO St. Joseph
- Agent Michael P. Morris; Joyce L. Morrison
- Main IPC: A61K39/12
- IPC: A61K39/12 ; C07H21/04 ; C12N7/00 ; C12N15/86

Abstract:
Substantially avirulent forms of atypical porcine reproductive and respiratory syndrome (PRRS) virus and corresponding vaccines are provided which result from cell culture passaging of virulent forms of PRRS. The resultant avirulent atypical PRRS virus is useful as a vaccine in that PRRS specific antibody response is elicited by inoculation of host animals, thereby conferring effective immunity against both previously known strains of PRRS virus and newly isolated atypical PRRS virus strains. The preferred passaging technique ensures that the virus remains in a logarithmic growth phase substantially throughout the process, which minimizes the time required to achieve attenuation. The present invention also provides diagnostic testing methods which can differentiate between animals infected with field strains and attenuated strains of PRRSV.
Public/Granted literature
- US08491916B2 Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142 Public/Granted day:2013-07-23
Information query